The Trump administration has unveiled 15 new drugs selected for a Medicare drug price negotiation program that allows the ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower ...

List includes medications for diabetes, cancer, arthritis, and more ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

By Michael Erman and Deena Beasley Jan 27 (Reuters) - The U.S. government on Tuesday named the 15 new drugs targeted for ...

The Trump administration on Tuesday announced the 15 drugs selected to participate in the newest round of the Medicare Drug ...

The Centers for Medicare & Medicaid Services (CMS) announced that Botox is among 15 prescription drugs newly added to the ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

About 1.8 million people used one or more of the 15 drugs through Medicare Part D or Part B between November 2024 and October 2025, the CMS said. The batch of 15 meds accounted for about $27 billion ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.